ARMP
Price
$1.95
Change
-$0.05 (-2.50%)
Updated
Dec 18 closing price
84 days until earnings call
INNMF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Dec 16 closing price
Ad is loading...

ARMP vs INNMF

Header iconARMP vs INNMF Comparison
Open Charts ARMP vs INNMFBanner chart's image
Armata Pharmaceuticals
Price$1.95
Change-$0.05 (-2.50%)
Volume$18.67K
CapitalizationN/A
Amplia Therapeutics
Price$0.06
Change-$0.00 (-0.00%)
Volume$11.24K
CapitalizationN/A
ARMP vs INNMF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARMP vs. INNMF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a StrongBuy and INNMF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ARMP: $1.95 vs. INNMF: $0.05)
Brand notoriety: ARMP and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 201% vs. INNMF: 61%
Market capitalization -- ARMP: $70.56M vs. INNMF: $20.75M
ARMP [@Biotechnology] is valued at $70.56M. INNMF’s [@Biotechnology] market capitalization is $20.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileINNMF’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • INNMF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than ARMP.

Price Growth

ARMP (@Biotechnology) experienced а -11.36% price change this week, while INNMF (@Biotechnology) price change was +8.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.12%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was -1.61%.

Reported Earning Dates

ARMP is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-7.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ARMP($70.6M) has a higher market cap than INNMF($20.7M). INNMF YTD gains are higher at: 5.465 vs. ARMP (-39.815).
ARMPINNMFARMP / INNMF
Capitalization70.6M20.7M341%
EBITDAN/AN/A-
Gain YTD-39.8155.465-729%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash37.9MN/A-
Total Debt168MN/A-
FUNDAMENTALS RATINGS
ARMP vs INNMF: Fundamental Ratings
ARMP
INNMF
OUTLOOK RATING
1..100
6128
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
8254
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
853

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (36) in the null industry is somewhat better than the same rating for ARMP (81) in the Biotechnology industry. This means that INNMF’s stock grew somewhat faster than ARMP’s over the last 12 months.

INNMF's Profit vs Risk Rating (98) in the null industry is in the same range as ARMP (100) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

INNMF's SMR Rating (97) in the null industry is in the same range as ARMP (100) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

INNMF's Price Growth Rating (54) in the null industry is in the same range as ARMP (82) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

ARMP's P/E Growth Rating (93) in the Biotechnology industry is in the same range as INNMF (100) in the null industry. This means that ARMP’s stock grew similarly to INNMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

ARMP and

Correlation & Price change

A.I.dvisor tells us that ARMP and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-2.50%
FGHQF - ARMP
25%
Poorly correlated
N/A
QSI - ARMP
23%
Poorly correlated
-6.57%
ADPT - ARMP
22%
Poorly correlated
-8.44%
ALT - ARMP
22%
Poorly correlated
-5.95%
PRME - ARMP
22%
Poorly correlated
-9.28%
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and CGEN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
N/A
CGEN - INNMF
24%
Poorly correlated
-5.03%
ALVR - INNMF
24%
Poorly correlated
-1.53%
HOFBF - INNMF
22%
Poorly correlated
N/A
EXEL - INNMF
21%
Poorly correlated
-2.97%
ARMP - INNMF
21%
Poorly correlated
-2.50%
More